C12Y 114/1103
Hypoxia-inducible factor-asparagine dioxygenase
Official title: Hypoxia-inducible factor-asparagine dioxygenase (1.14.11.30)
C12Y114/1103 (Hypoxia-inducible factor-asparagine dioxygenase) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 5
- Assignees
- 3
- Inventors
- 10
- Latest grant
- 4 Jul 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
By publication year.
Recent patents
- Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase4 Jul 2017US 9,695,170 B2FibroGen, Inc.
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase1 Mar 2016US 9,271,970 B2FibroGen, Inc.
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase30 Dec 2014US 8,921,389 B2FibroGen, Inc.
- Cells having high adaptability under hypoxic conditions, and use thereof2 Mar 2023US 2023/0063739 A1Toolgen Incorporated
- Pharmaceutical composition for preventing or treating alzheimer's and use thereof23 Feb 2023US 2023/0053781 A1Samsung Life Public Welfare Foundation
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase9 Jun 2016US 2016/0159796 A1FibroGen, Inc.
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase25 Jun 2015US 2015/0174110 A1FibroGen, Inc.
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase27 Mar 2014US 2014/0088101 A1FibroGen, Inc.
Most cited
By later US patents
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase15US 8,921,389 B2FibroGen, Inc. · 2014
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase7US 9,271,970 B2FibroGen, Inc. · 2016
- Naphthyridine derivatives as inhibitors of Hypoxia inducible factor (HIF) hydroxylase5US 9,695,170 B2FibroGen, Inc. · 2017